Source: International Forum of Allergy and Rhinology. Unidade: FMRP
Subjects: SINUSITE CRÔNICA, BACTERIOLOGIA, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABINO, Henrique Augusto Cantareira et al. Amoxicillin‐clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double‐blinded, placebo‐controlled trial. International Forum of Allergy and Rhinology, v. 7, n. 2, p. 135-142, 2017Tradução . . Disponível em: https://doi.org/10.1002/alr.21846. Acesso em: 17 out. 2024.APA
Sabino, H. A. C., Valera, F. C. P., Aragon, D. C., Fantucci, M. Z., Titoneli, C. C., Martinez, R., et al. (2017). Amoxicillin‐clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double‐blinded, placebo‐controlled trial. International Forum of Allergy and Rhinology, 7( 2), 135-142. doi:10.1002/alr.21846NLM
Sabino HAC, Valera FCP, Aragon DC, Fantucci MZ, Titoneli CC, Martinez R, Anselmo-Lima WT, Tamashiro E. Amoxicillin‐clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double‐blinded, placebo‐controlled trial [Internet]. International Forum of Allergy and Rhinology. 2017 ; 7( 2): 135-142.[citado 2024 out. 17 ] Available from: https://doi.org/10.1002/alr.21846Vancouver
Sabino HAC, Valera FCP, Aragon DC, Fantucci MZ, Titoneli CC, Martinez R, Anselmo-Lima WT, Tamashiro E. Amoxicillin‐clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double‐blinded, placebo‐controlled trial [Internet]. International Forum of Allergy and Rhinology. 2017 ; 7( 2): 135-142.[citado 2024 out. 17 ] Available from: https://doi.org/10.1002/alr.21846